Results
15
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
15 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
SPOK | US$16.43 | -2.9% | -2.9% | US$344.2m | US$15.00 | PE22.7x | E7.4% | 7.8% | ||
IDT | US$48.62 | 0.04% | 35.4% | US$1.3b | n/a | PE16.6x | n/a | 0.4% | ||
IGLD.F | US$1.97 | 0% | n/a | US$4.4m | n/a | PB2.7x | n/a | n/a | ||
CIBY | US$1,650.25 | -1.2% | n/a | US$35.5m | n/a | PE170.8x | n/a | n/a | ||
NXPL | US$0.98 | -7.1% | -31.5% | US$26.0m | n/a | PS0.4x | n/a | n/a | ||
FULO | US$0.34 | 39.4% | 30.2% | US$4.5m | n/a | PE14.3x | n/a | 4.4% | ||
KTEL | US$0.30 | -3.1% | -57.7% | US$13.9m | n/a | PE3.2x | n/a | n/a | ||
MACT | US$7.20 | 2.9% | -3.2% | US$18.7m | n/a | PE5x | n/a | n/a | ||
UCL | US$1.26 | 0% | -28.0% | US$49.1m | US$9.50 | PE11.2x | S14.5% | n/a | ||
FNGR | US$1.37 | 17.1% | -54.0% | US$74.3m | n/a | PS2.3x | n/a | n/a | ||
ATEX | US$39.05 | -6.3% | 2.1% | US$750.7m | US$80.67 | PS123x | E21.2% | n/a | ||
VPLM | US$0.012 | -15.9% | -26.6% | US$45.5m | n/a | PB24.9x | n/a | n/a | ||
SURG | US$1.37 | -6.2% | -80.5% | US$27.8m | US$5.75 | PS0.3x | E107.1% | n/a | ||
LICT New | US$14,500.00 | -2.7% | -18.5% | US$239.8m | n/a | PE10.3x | n/a | n/a | ||
ASTS | US$28.64 | -10.8% | 870.8% | US$9.2b | US$34.20 | PS2295.1x | E52.8% | n/a |